Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02187770Completed

Precision of IMED-4 Lung Fluid Measurements

Role: lead

NCT02111525Completed

Fluid Status of Outpatients With Dyspnea

Role: lead

NCT02426593Completed

Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology

Role: lead

NCT02191696Completed

Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation

Role: lead

All 4 trials loaded